Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine
Hiromi Muramatsu, Kieu Lam, Csaba Bajusz, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1941-1951
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

mRNA-based cancer therapeutics
Chuang LIU, Qiangqiang Shi, Xiangang Huang, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 526-543
Closed Access | Times Cited: 201
A Comprehensive Review of mRNA Vaccines
Vrinda Gote, Pradeep Kumar Bolla, Nagavendra Kommineni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2700-2700
Open Access | Times Cited: 180
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 739-754
Open Access | Times Cited: 127
The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case
Erik Oude Blenke, Eivor Örnskov, Christian Schöneich, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 112, Iss. 2, pp. 386-403
Open Access | Times Cited: 101
Nanotechnology-based mRNA vaccines
Shuying Chen, Xiangang Huang, Yonger Xue, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 70
Fabrication of active targeting lipid nanoparticles: Challenges and perspectives
Ipshita Menon, Maryam Zaroudi, Yuanzhe Zhang, et al.
Materials Today Advances (2022) Vol. 16, pp. 100299-100299
Closed Access | Times Cited: 69
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
mRNA in the Context of Protein Replacement Therapy
Theofanis Vavilis, Εleni Stamoula, Alexandra Ainatzoglou, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 166-166
Open Access | Times Cited: 63
Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures
Sofie Meulewaeter, Gust Nuytten, Miffy H. Y. Cheng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 149-160
Open Access | Times Cited: 61
Lipid nanoparticles for siRNA delivery in cancer treatment
Souhaila H. El Moukhtari, Elisa Garbayo, Ane Amundarain, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 130-146
Closed Access | Times Cited: 60
Research Advances on the Stability of mRNA Vaccines
Feiran Cheng, Yi‐Ping Wang, Yu Bai, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 668-668
Open Access | Times Cited: 59
mRNA vaccine in cancer therapy: Current advance and future outlook
Youhuai Li, Mina Wang, Xueqiang Peng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 57
Microfluidics for nano-drug delivery systems: From fundamentals to industrialization
Huan Zhang, Jie Yang, Rongze Sun, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3277-3299
Open Access | Times Cited: 55
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2
Liangxia Ai, Yafei Li, Li Zhou, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid
Yaru Jia, Xiu‐Guang Wang, Luwei Li, et al.
Advanced Materials (2023) Vol. 36, Iss. 4
Closed Access | Times Cited: 46
Optimizing Lipid Nanoparticles for Delivery in Primates
Kieu Lam, Petra Schreiner, Ada Leung, et al.
Advanced Materials (2023) Vol. 35, Iss. 26
Open Access | Times Cited: 45
Recent advances in nanoparticulate RNA delivery systems
Jacob Witten, Yizong Hu, Róbert Langer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 36
The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 34
A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century
Jingyu Wang, Wenling Zhao, Zhao Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 32
Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up
Rijo John, Jasmin monpara, Shankar Swaminathan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 131-131
Open Access | Times Cited: 24
Breaking the mold with RNA—a “RNAissance” of life science
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 16
Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
Byungji Kim, Ryan R. Hosn, Tanaka Remba, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 241-253
Open Access | Times Cited: 60
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
Emily A. Voigt, Alana Gerhardt, Derek Hanson, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top